Q32 Bio (QTTB) Non-Current Assets (2017 - 2026)

Q32 Bio's Non-Current Assets history runs 10 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 37.99% year-over-year to $6.5 million in Q1 2026; TTM through Mar 2026 was $28.0 million, a 36.62% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 35.67% from the prior year.
• Non-Current Assets fell to $6.5 million in Q1 2026 per QTTB's latest filing, from $6.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $228.7 million in Q4 2022 and bottomed at $6.5 million in Q1 2026.
• The 5-year median for Non-Current Assets is $14.3 million (2024), against an average of $38.2 million.
• Across the five-year window, Non-Current Assets soared 1054.58% in 2022 and tumbled 85.96% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $228.7 million in 2022, then slumped by 67.45% to $74.5 million in 2023, then tumbled by 85.96% to $10.5 million in 2024, then slumped by 35.67% to $6.7 million in 2025, then retreated by 3.76% to $6.5 million in 2026.
• Per Business Quant, the three latest QTTB Non-Current Assets figures stand at $6.5 million (Q1 2026), $6.7 million (Q4 2025), and $7.0 million (Q3 2025).